Standardless 1H NMR determination of pharmacologically active substances in dietary supplements and medicines that have been illegally traded over the Internet

Drug Testing and Analysis

Volumn 5, Issue 6, 2013, Pages 400-411

  Monakhova, Yulia B ^a,b,c   Kuballa, Thomas ^a   Löbell Behrends, Sigrid ^a   Maixner, Sibylle ^a   Kohl Himmelseher, Matthias ^a   Ruge, Winfried ^a   Lachenmeier, Dirk W ^a  

^a Chemisches und Veterinaruntersuchungsamt CVUA Karlsruhe   (Germany)

^b BRUKER BIOSPIN GMBH   (Germany)

^c SARATOV STATE UNIVERSITY   (Russian Federation)

Author keywords

Androgens; Appetite depressants; Dietary supplements; NMR; Standardless quantification

Indexed keywords

CALIBRATION; CHROMATOGRAPHIC ANALYSIS; COMMERCE; FOOD ADDITIVES; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUTRITION; VITAMINS;

ANDROGEN; APPETITE DEPRESSANT; GASCHROMATOGRAPHY-MASS SPECTROMETRY; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY ANALYSIS; PEAKS AREAS; PHARMACOLOGICALLY ACTIVE SUBSTANCES; QUANTITATIVE ESTIMATION; REFERENCE SUBSTANCE; STANDARDLESS QUANTIFICATIONS;

DIETARY SUPPLEMENTS;

CAFFEINE; EVODIAMINE; KAWAIN; MESTEROLONE; MEVINOLIN; OXYMETHOLONE; PRASTERONE; SIBUTRAMINE; VINPOCETINE;

ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG MARKETING; INTERNET; LIMIT OF DETECTION; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

DIETARY SUPPLEMENTS; INTERNET; MAGNETIC RESONANCE SPECTROSCOPY; SENSITIVITY AND SPECIFICITY;

EID: 84879030555     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1367     Document Type: Article

References (49)

1. S. Löbell-Behrends, S. Maixner, E. Kratz, M. Kohl-Himmelseher, H. Bauer-Aymanns, G. Marx, et al. Surveillance of internet marketing of borderline products (anti-aging and weight-loss supplements): A pilot study. Deut. Lebensm-Rundschau. 2008, 104, 265.
2. S. Löbell-Behrends, D. Schweizer, M. Kohl-Himmelseher, S. Maixner, G. Marx, D.W. Lachenmeier 'Sports food' - internet marketing of products advertised as hormone-modulating or pharmaceutically active. Deut. Lebensm-Rundschau. 2008, 104, 415.
3. A. Petroczi, G. Taylor, D.P. Naughton Mission impossible? Regulatory and enforcement issues to ensure safety of dietary supplements. Food Chem. Toxicol. 2011, 49, 393.
4. W. Böse, S. Löbell-Behrends, S. Maixner, E. Kratz, M. Kohl-Himmelseher, G. Marx, et al. Control of internet commerce in food - towards an effective sampling. Deut. Lebensm-Rundschau. 2011, 107, 84.
5. S. Löbell-Behrends, W. Böse, S. Maixner, E. Kratz, M. Kohl-Himmelseher, G. Marx, et al. Surveillance of internet marketing of food products - categorization of borderline products and concepts for effective control strategies. J. Verbr. Lebensm. 2011, 6, 385.
6. S.R. Gratz, C.L. Flurer, K.A. Wolnik Analysis of undeclared synthetic phosphodiesterase-5 inhibitors in dietary supplements and herbal matrices by LC-ESI-MS and LC-UV. J. Pharm. Biomed. Anal. 2004, 36, 525.
7. P. Zou, S.S.Y. Oh, P.L. Hou, M.Y. Low, H.L. Koh Simultaneous determination of synthetic phosphodiesterase-5 inhibitors found in a dietary supplement and pre-mixed bulk powders for dietary supplements using high-performance liquid chromatography with diode array detection and liquid chromatography-electrospray ionization tandem mass spectrometry. J. Chromatogr. A 2006, 1104, 113.
8. J. Reepmeyer, J. Woodruff Use of liquid chromatography-mass spectrometry and a hydrolytic technique for the detection and structure elucidation of a novel synthetic vardenafil designer drug added illegally to a 'natural' herbal dietary supplement. J. Chromatogr. A 2006, 1125, 67.
9. H. Geyer, U. Mareck-Engelke, U. Reinhart, M. Thevis, W. Schänzer Positive doping cases with norandrosterone after application of contaminated nutritional supplements. Dtsch. Z. Sportmed. 2000, 51, 378.
10. A. Thomas, M. Kohler, J. Mester, H. Geyer, W. Schaenzer, M. Petrou, et al. Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement. Drug Test. Anal. 2010, 2, 144.
11. L.M. de Carvalho, M. Martini, A.P.L. Moreira, A.P.S. de Lima, D. Correia, T. Falcao, et al. Presence of synthetic pharmaceuticals as adulterants in slimming phytotherapeutic formulations and their analytical determination. Forensic Sci. Int. 2011, 204, 6.
12. M. Kohler, A. Thomas, H. Geyer, M. Petrou, W. Schanzer, M. Thevis Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the Cologne doping control laboratory 2009. Drug Test. Anal. 2010, 2, 533.
13. M. Okano, M. Sato, A. Ikekita, S. Kageyama Analysis of non-ketoic steroids 17α-methylepithiostanol and desoxymethyl-testosterone in dietary supplements. Drug Test. Anal. 2009, 1, 518.
14. D.W. Lachenmeier, E. Humpfer, F. Fang, B. Schütz, P. Dvortsak, C. Sproll, et al. NMR-spectroscopy for nontargeted screening and simultaneous quantification of health-relevant compounds in foods: the example of melamine. J. Agric. Food Chem. 2009, 57, 7194.
15. P. Zou, P. Hou, S.S.-Y. Oh, X. Ge, B.C. Bloodworth, M.Y. Low, et al. Identification of benzamidenafil, a new class of phosphodiesterase-5 inhibitor, as an adulterant in a dietary supplement. J. Pharm. Biomed. Anal. 2008, 47, 255.
16. G.M. Hanna NMR regulatory analysis: Determination and characterization of S-adeno-syl-L-methionine in dietary supplements. Pharmazie 2004, 59, 251.
17. K.C. Lai, Y.C. Liu, M.C. Tseng, J.H. Lin Isolation and identification of a sildenafil analogue illegally added in dietary supplements. J. Food Drug Anal. 2006, 14, 19.
18. K.C. Lai, Y.C. Liu, M.C. Tseng, Y.L. Lin, J.H. Lin Isolation and identification of a sibutramine analogue in a healthy food for weight loss. J. Food Drug Anal. 2007, 15, 20.
19. J. Vaysse, S. Balayssac, V. Gilard, D. Desoubdzanne, M. Malet-Martino, R. Martino Analysis of adulterated herbal medicines and dietary supplements marketed for weight loss by DOSY 1H-NMR. Food Addit. Contam. Part A 2010, 27, 903.
20. S. Balayssac, S. Trefi, V. Gilard, M. Malet-Martino, R. Martino, M.A. Delsuc 2D and 3D DOSY (1)H NMR, a useful tool for analysis of complex mixtures: Application to herbal drugs or dietary supplements for erectile dysfunction. J. Pharm. Biomed. Anal. 2009, 50, 602.
21. U. Holzgrabe, R. Deubner, C. Schollmayer, B. Waibel Quantitative NMR spectroscopy - Applications in drug analysis. J. Pharm. Biomed. Anal. 2005, 38, 806.
22. M. Spraul, E. Humpfer, H. Schäfer, B. Schütz, M. Mörtter, P. Rinke NMR-based mixture analysis on the example of fruit juice quality control using statistics and quantification, in NMR Spectroscopy in Pharmaceutical Analysis, (Eds: U. Holzgrabe, I. Wawer, B. Diehl). Elsevier: Amsterdam, 2008, pp. 319-329.
23. H. Köbler, Y.B. Monakhova, T. Kuballa, C. Tschiersch, J. Vancutsem, G. Thielert, et al. Nuclear magnetic resonance spectroscopy and chemometrics to identify pine nuts that cause taste disturbance. J. Agric. Food Chem. 2011, 59, 6877.
24. Y.B. Monakhova, H. Schafer, E. Humpfer, M. Spraul, T. Kuballa, D.W. Lachenmeier Application of automated eightfold suppression of water and ethanol signals in (1) H NMR to provide sensitivity for analyzing alcoholic beverages. Magn. Reson. Chem. 2011, 49, 734.
25. D.P. Hollis Quantitative analysis of aspirin, phenacetin, and caffeine mixtures by nuclear magnetic resonance spectrometry. Anal. Chem. 1963, 35, 1682.
26. T. Rundlof, M. Mathiasson, S. Bekiroglu, B. Hakkarainen, T. Bowden, T. Arvidsson Survey and qualification of internal standards for quantification by (1)H NMR spectroscopy. J. Pharm. Biomed. Anal. 2010, 52, 645.
27. U. Holzgrabe Quantitative NMR spectroscopy in pharmaceutical applications. Prog. Nucl. Mag. Res. Sp. 2010, 57, 229.
28. M. Malet-Martino, U. Holzgrabe NMR techniques in biomedical and pharmaceutical analysis. J. Pharm. Biomed. Anal. 2011, 55, 1.
29. G.F. Pauli, B.U. Jaki, D.C. Lankin Quantitative H-1 NMR: Development and potential of a method for natural products analysis. J. Nat. Prod. 2005, 68, 133.
30. F. Malz, H. Jancke Validation of quantitative NMR. J. Pharm. Biomed. Anal. 2005, 38, 813.
31. R.B. Schaller, M.E. Munk, E. Pretsch Spectra estimation for computer-aided structure determination. J. Chem. Inf. Comp. Sci. 1996, 36, 239.
32. M.T. Liu, J.J. Li, X.Y. Shang, S. Li, L.L. Li, N. Luan, et al. Structure elucidation and complete NMR spectral assignment of an unusual aromatic monacolin analog from Monascus purpureus-fermented rice. Magn. Reson. Chem. 2011, 49, 129.
33. T. Beyer, C. Schollmayer, U. Holzgrabe The role of solvents in the signal separation for quantitative (1)H NMR spectroscopy. J. Pharm. Biomed. Anal. 2010, 52, 51.
34. B.S. Joshi, K.M. Moore, S.W. Pelletier Alkaloids of Zanthoxzlum budrunga Wall.: NMR assignments of dihydrochelerythrine, (±)-evodiamine and zanthobungeanine. Phytochem. Anal. 1991, 2, 20.
35. C.K. Larive, D. Jayawickrama, L. Orfi Quantitative analysis of peptides with NMR spectroscopy. Appl. Spectrosc. 1997, 51, 1531.
36. M.J. Albers, T.N. Butler, I. Rahwa, N. Bao, K.R. Keshari, M.G. Swanson, et al. Evaluation of the ERETIC method as an improved quantitative reference for (1)H HR-MAS spectroscopy of prostate tissue. Magnet. Reson. Med. 2009, 61, 525.
37. L. Dreier, G. Wider Concentration measurements by PULCON using X-filtered or 2D NMR spectra. Magn. Reson. Chem. 2006, 44, S206-S212.
38. S. Akoka, L. Barantin, M. Trierweiler Concentration measurement by proton NMR using the ERETIC method. Anal. Chem. 1999, 71, 2554.
39. V. Molinier, B. Fenet, J. Fitremann, A. Bouchu, Y. Queneau Concentration measurements of sucrose and sugar surfactants solutions by using the H-1 NMR ERETIC method. Carbohyd. Res. 2006, 341, 1890.
40. F. Ziarelli, S. Viel, S. Sanchez, D. Cross, S. Caldarelli Precision and sensitivity optimization of quantitative measurements in solid state NMR. J. Magn. Reson. 2007, 188, 260.
41. M. Carmen Martinez-Bisbal, D. Monleon, O. Assemat, M. Piotto, J. Piquer, J. Luis Llacer, et al. Determination of metabolite concentrations in human brain tumour biopsy samples using HR-MAS and ERETIC measurements. NMR Biomed. 2009, 22, 199.
42. S. Heinzer-Schweizer, N. De Zanche, M. Pavan, G. Mens, U. Sturzenegger, A. Henning, et al. In-vivo assessment of tissue metabolite levels using 1H MRS and the Electric REference To access In vivo Concentrations (ERETIC) method. NMR Biomed. 2010, 23, 406.
43. K.I. Marro, D. Lee, E.G. Shankland, C. Mathis, C.E. Hayes, S.D. Friedman, et al. Quantitative in vivo magnetic resonance spectroscopy using synthetic signal injection. PLoS One 2010, 5.
44. S. Nie, X. Fan, Y. Peng, X. Yang, C. Wang, W. Pan In Vitro and In Vivo studies on the complexes of vinpocetine with hydroxypropyl-â-cyclodextrin. Arch. Pharm. Res. 2006, 30, 991.
45. L. Ribeiro, R.A. Carvalho, D.C. Ferreira, F.J.B. Veiga Multicomponent complex formation between vinpocetine, cyclodextrins, tartaric acid and water-soluble polymers monitored by NMR and solubility studies. Eur. J. Pharm. Sci. 2005, 24, 1.
46. T. Sohajda, E. Varga, R. Ivanyi, I. Fejos, L. Szente, B. Noszal, et al. Separation of vinca alkaloid enantiomers by capillary electrophoresis applying cyclodextrin derivatives and characterization of cyclodextrin complexes by nuclear magnetic resonance spectroscopy. J. Pharm. Biomed. Anal. 2010, 53, 1258.
47. L.S. Kan, P.N. Borer, D.M. Cheng, P.O.P. Tso H-1-Nmr and C-13-Nmr studies on caffeine and its interaction with nucleic-acids. Biopolymers 1980, 19, 1641.
48. G. Pescitelli, A. Bilia, M. Bergonzi, F. Vincieri, L. Di Bari Cyclodextrins as carriers for kavalactones in aqueous media: Spectroscopic characterization of (S)-7, 8-dihydrokavain and beta-cyclodextrin inclusion complex. J. Pharm. Biomed. Anal. 2010, 52, 479.
49. J.P. Burgess, J.S. Wintermute, B.F. Thomas, I.M. Kapetanovic Complete H-1 and C-13 assignments of fluorinated analogs of dehydroepiandrosterone. Magn. Reson. Chem. 2006, 44, 1051.